A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting
1 other identifier
observational
309
1 country
23
Brief Summary
The purpose of this study is to explore if certain characteristics, easily detected within a regular primary care setting, may indicate that a patient at risk for COPD (45 ≤ age ≤ 80 years and a smoking history of ≥ 15 pack years) is prone to have a diagnosis of COPD according to Medical Products Agency guidelines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2009
Shorter than P25 for all trials
23 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 13, 2009
CompletedFirst Posted
Study publicly available on registry
November 16, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2010
CompletedNovember 19, 2010
November 1, 2010
5 months
November 13, 2009
November 18, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The patients will test their lung function with a COPD-6 screener for COPD and compare with regular spirometry. Medical records will be checked for health care contacts with respiratory diagnosis during the last 24 months prior to the study visit.
There will only be one visit in the study
Study Arms (1)
No treatment
Patients with a smoking history of 15 pack years or more.
Eligibility Criteria
Primary care clinic
You may qualify if:
- Patients with a history of smoking one pack of cigarettes per day for 15 years or more
You may not qualify if:
- Known Chronic Obstructive Pulmonary Disease
- Known severe cardiovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (23)
Research Site
Alingsås, Sweden
Research Site
Arvidsjaur, Sweden
Research Site
Askim, Sweden
Research Site
Åtvidaberg, Sweden
Research Site
Bromma, Sweden
Research Site
Eslöv, Sweden
Research Site
Falun, Sweden
Research Site
Gagnef, Sweden
Research Site
Gothenburg, Sweden
Research Site
Hagfors, Sweden
Research Site
Helsingborg, Sweden
Research Site
Hisings Kärra, Sweden
Research Site
Höllviken, Sweden
Research Site
Järpen, Sweden
Research Site
Karlshamn, Sweden
Research Site
Karlskrona, Sweden
Research Site
Kil, Sweden
Research Site
Limhamn, Sweden
Research Site
Linköping, Sweden
Research Site
Luleå, Sweden
Research Site
Stockholm, Sweden
Research Site
Timrå, Sweden
Research Site
Värnamo, Sweden
Related Publications (1)
Thorn J, Tilling B, Lisspers K, Jorgensen L, Stenling A, Stratelis G. Improved prediction of COPD in at-risk patients using lung function pre-screening in primary care: a real-life study and cost-effectiveness analysis. Prim Care Respir J. 2012 Jun;21(2):159-66. doi: 10.4104/pcrj.2011.00104.
PMID: 22270480DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Björn Tilling
Åtvidabergs vårdcentral
- STUDY DIRECTOR
Georgios Stratelis
AstraZeneca
Study Design
- Study Type
- observational
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 13, 2009
First Posted
November 16, 2009
Study Start
October 1, 2009
Primary Completion
March 1, 2010
Study Completion
March 1, 2010
Last Updated
November 19, 2010
Record last verified: 2010-11